DZ2012A1 - Benzamides pour le traitement de dégénérescences neurologiques. - Google Patents

Benzamides pour le traitement de dégénérescences neurologiques.

Info

Publication number
DZ2012A1
DZ2012A1 DZ960053A DZ960053A DZ2012A1 DZ 2012 A1 DZ2012 A1 DZ 2012A1 DZ 960053 A DZ960053 A DZ 960053A DZ 960053 A DZ960053 A DZ 960053A DZ 2012 A1 DZ2012 A1 DZ 2012A1
Authority
DZ
Algeria
Prior art keywords
degenerations
benzamides
neurological
treatment
neurological degenerations
Prior art date
Application number
DZ960053A
Other languages
English (en)
Inventor
William David Flitter
Williams A Garland
Allan L Wilcox
Richard E Taylor
Original Assignee
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/415,847 external-priority patent/US5643965A/en
Priority claimed from US08/415,694 external-priority patent/US5658953A/en
Priority claimed from US08/415,248 external-priority patent/US5659082A/en
Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc
Application granted granted Critical
Publication of DZ2012A1 publication Critical patent/DZ2012A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DZ960053A 1995-04-03 1996-03-27 Benzamides pour le traitement de dégénérescences neurologiques. DZ2012A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41567795A 1995-04-03 1995-04-03
US08/415,847 US5643965A (en) 1995-04-03 1995-04-03 Aminobenzamide compounds for the treatment of neurodegenerative disorders
US08/415,694 US5658953A (en) 1995-04-03 1995-04-03 Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US08/415,248 US5659082A (en) 1995-04-03 1995-04-03 Nitro- and aminobenzamide compounds for neurodegenerative disorders

Publications (1)

Publication Number Publication Date
DZ2012A1 true DZ2012A1 (fr) 2002-07-21

Family

ID=27503636

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ960053A DZ2012A1 (fr) 1995-04-03 1996-03-27 Benzamides pour le traitement de dégénérescences neurologiques.

Country Status (38)

Country Link
EP (1) EP0819113B1 (fr)
JP (1) JP3479658B2 (fr)
KR (1) KR100429120B1 (fr)
CN (1) CN1073552C (fr)
AR (1) AR002978A1 (fr)
AT (1) ATE202552T1 (fr)
AU (1) AU721045B2 (fr)
BG (1) BG63384B1 (fr)
CA (1) CA2215166A1 (fr)
CO (1) CO4700431A1 (fr)
CZ (1) CZ295852B6 (fr)
DE (1) DE69613567T2 (fr)
DK (1) DK0819113T3 (fr)
DZ (1) DZ2012A1 (fr)
EA (1) EA002031B1 (fr)
EE (1) EE03437B1 (fr)
ES (1) ES2160240T3 (fr)
GR (1) GR3036466T3 (fr)
HR (1) HRP960156B1 (fr)
HU (1) HUP9801759A3 (fr)
IL (1) IL117629A (fr)
IS (1) IS1919B (fr)
MA (1) MA23837A1 (fr)
MX (1) MX9707596A (fr)
MY (1) MY121206A (fr)
NO (1) NO318441B1 (fr)
NZ (1) NZ306204A (fr)
PL (1) PL184121B1 (fr)
PT (1) PT819113E (fr)
RO (1) RO116190B1 (fr)
SA (1) SA96160739B1 (fr)
SI (1) SI0819113T1 (fr)
SK (1) SK282900B6 (fr)
TN (1) TNSN96051A1 (fr)
TR (1) TR199701114T1 (fr)
TW (1) TW381073B (fr)
WO (1) WO1996031462A1 (fr)
YU (1) YU21096A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2252403A1 (fr) * 1996-04-17 1997-10-23 William Garland Traitement par benzamides de la demence associee a l'infection par le virus du sida (vih-1)
EP1034783B1 (fr) 1997-10-27 2004-12-15 Sumitomo Pharmaceuticals Company, Limited Derives d'amide pour le traitement des maladies neurodegeneratives de la retina
AU3985699A (en) 1998-05-19 1999-12-06 Centaur Pharmaceuticals, Inc. Amide therapeutics for the treatment of inflammatory bowel disease
WO1999059569A1 (fr) * 1998-05-19 1999-11-25 Centaur Pharmaceuticals, Inc. Medicament a base de benzamide, destine au traitement des affections inflammatoires de l'intestin
WO2000064430A1 (fr) * 1999-04-23 2000-11-02 Sumitomo Pharmaceuticals Co., Ltd. Inhibiteurs de l'apoptose
CN101817761B (zh) * 2010-01-29 2014-06-25 浙江大学 苯甲酸酯类衍生物及制备方法和应用
JP5850321B2 (ja) * 2010-02-10 2016-02-03 公立大学法人横浜市立大学 神経選択的転写抑制因子ＮＲＳＦに特異的に結合するｍＳｉｎ３Ｂに結合する化合物の利用
WO2014155184A1 (fr) * 2013-03-28 2014-10-02 Rhenovia Pharma Traitement pour maladie de parkinson
CN115594603A (zh) * 2022-10-09 2023-01-13 湖北师范大学（Cn） 微通道反应器制备n-叔丁基-4-氨基苯甲酰胺的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1069882B (it) * 1975-12-22 1985-03-25 Mallinckrodt Inc 3 5 bis acilammino benzammidi particolarmente utili come agenti di contrasto per raffi x e procedimento per la loro preparazione
JPS5721320A (en) * 1980-07-11 1982-02-04 Chugai Pharmaceut Co Ltd Blood sugar level depressing agent
JPS5867657A (ja) * 1981-10-15 1983-04-22 Chugai Pharmaceut Co Ltd ペンズアミド誘導体
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
KR19980703562A (ko) 1998-11-05
MX9707596A (es) 1998-06-30
IL117629A (en) 2000-08-13
DE69613567T2 (de) 2002-04-18
JP3479658B2 (ja) 2003-12-15
YU21096A (sh) 1999-03-04
IS1919B (is) 2004-03-15
AU5440496A (en) 1996-10-23
SI0819113T1 (en) 2001-10-31
NO318441B1 (no) 2005-03-21
HRP960156A2 (en) 1997-10-31
HK1016964A1 (en) 1999-11-12
EP0819113A1 (fr) 1998-01-21
EP0819113B1 (fr) 2001-06-27
ES2160240T3 (es) 2001-11-01
NZ306204A (en) 1999-01-28
AU721045B2 (en) 2000-06-22
SK132597A3 (en) 1998-09-09
NO974569L (no) 1997-11-21
PL322625A1 (en) 1998-02-02
ATE202552T1 (de) 2001-07-15
DK0819113T3 (da) 2001-10-15
HRP960156B1 (en) 2002-04-30
WO1996031462A1 (fr) 1996-10-10
MA23837A1 (fr) 1996-12-31
IL117629A0 (en) 1996-07-23
PL184121B1 (pl) 2002-09-30
CZ295852B6 (cs) 2005-11-16
GR3036466T3 (en) 2001-11-30
HUP9801759A2 (hu) 1998-12-28
EA002031B1 (ru) 2001-12-24
CN1073552C (zh) 2001-10-24
TW381073B (en) 2000-02-01
CZ309897A3 (cs) 1998-12-16
CO4700431A1 (es) 1998-12-29
BG63384B1 (bg) 2001-12-29
DE69613567D1 (de) 2001-08-02
EA199700287A1 (ru) 1998-04-30
HUP9801759A3 (en) 2001-06-28
EE03437B1 (et) 2001-06-15
KR100429120B1 (ko) 2004-08-18
SA96160739B1 (ar) 2005-10-15
MY121206A (en) 2006-01-28
TNSN96051A1 (fr) 2005-03-15
IS4569A (is) 1997-09-25
TR199701114T1 (xx) 1998-02-21
RO116190B1 (ro) 2000-11-30
PT819113E (pt) 2001-10-30
AR002978A1 (es) 1998-05-27
BG101929A (en) 1998-04-30
CN1182416A (zh) 1998-05-20
CA2215166A1 (fr) 1996-10-10
JPH11501319A (ja) 1999-02-02
SK282900B6 (sk) 2003-01-09
EE9700235A (et) 1998-04-15
NO974569D0 (no) 1997-10-02

Similar Documents

Publication Publication Date Title
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
ZA9610139B (en) Treatment of the cns effects of hiv
FR2663044B1 (fr) Appareil pour le traitement de surfaces.
MA25404A1 (fr) Methode pour le traitement des desordres neurologiques ou neuropsychiatriques.
EP0673384A4 (fr) Polypeptides utiles pour traiter des troubles inflammatoires.
EP0655697A3 (fr) Appareil pour la représentation de diagrammes.
DE69627414D1 (de) Zusammensetzung effektiv für die Entfernung von Asphalten
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR2705966B1 (fr) Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
FR2652759B1 (fr) Catalyseurs pour le traitement des effluents gazeux et procede de traitement de ces effluents.
EP0669363A3 (fr) Procédé de préparation de polyorganosilane.
EP0761604A3 (fr) Agent pour le traitement des eaux
DZ1946A1 (fr) Procédé pour la préparation de supports.
DZ2012A1 (fr) Benzamides pour le traitement de dégénérescences neurologiques.
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
FR2758465B1 (fr) Composition pour le traitement de l'amiante
FR2694384B1 (fr) Traitement de la surface de réfractaires.
MA24333A1 (fr) Utilisation de 1-hydroxy-2-pyridones pour le traitement de la dermatite seborrheique .
FR2728142B1 (fr) Composition pour le traitement anti-germinatif de tubercules ou de bulbes ; procede de traitement
FR2747398B1 (fr) Procede de traitement de surface d'une piece metallique
EP0743927A4 (fr) Procede ameliore pour le traitement des eaux usees
FR2692606B1 (fr) Machine pour le traitement du lit de ballast.
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.